Page 657 - TNFlipTest

Toronto Notes 2019 References Infectious Diseases ID57
Parasitic Infections
Center for Disease Control and Prevention. DPDX: identification and diagnosis of parasites of public health concern. Available from: http://www.dpd.cdc.gov/dpdx/Default.htm. Croft MA, Jacquerioz FA. Drugs for preventing malaria in travelers. Cochrane DB Syst Rev 2009;4:CD006491.
Infections in the Immunocompromised Host
Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:e56-93. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:731-757.
Fever of Unknown Origin
Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Internal Med 2003;253:263-275. Spira AM. Assessment of travellers who return home ill. Lancet 2003;361:1459-1469.
Nosocomial Infections
Pickering LK, Baker CJ, Long SS, et al. (editors). Red book: 2006 report of the committee on infectious diseases, 27th ed. Elk Grove Village: American Academy of Pediatrics, 2006. Staphylococcal infections.
Simor AE, Ofner-Agostini M, Gravel D, et al. Surveillance for methicillin-resistant staphylococcus aureus in Canadian hospitals – a report update from the Canadian Nosocomial Infection Surveillance Program. CCDR 2005;31(3):1-7. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007;44:178-185.
Travel Medicine
Boggild A, Ghesquiere W, McCarthy A. Fever in the returning international traveller: initial assessment guidelines. Can Comm Dis Report 2011;37:1-15. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. NEJM 2006;354:1119-1130. Luzuriaga K, Sullivan J. Infectious mononucleosis. NEJM 2010;362:1993-2000.
Re VL, Gluckman SJ. Fever in the returned traveler. Am Fam Physician 2003;68:1343-1350.
Ryan ET, Wilson ME, Kain KC. Illness after international travel. NEJM 2002;347:505-516. Spira AM. Assessment of travellers who return home ill. Lancet 2003;361:1459-1469.
Antimicrobials
e-CPS. Canadian Pharmacists Association, 2008. Available from: http://e-cps.pharmacists.ca. MD Consult Drugs Online. Available from: http://home.mdconsult.com/das/drugs/. Schlossberg D (editor). Current therapy of infectious disease, 2nd ed. St Louis: Mosby, 2001.
Antivirals
Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious disease, 7th ed. Churchill Livingstone, 2009.
Strategies for Management of Anti-retroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of anti-retroviral treatment. NEJM 2006;355:2283-2296.